Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55,063 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Central nervous system progression in advanced non-small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study.
Li MX, He H, Ruan ZH, Zhu YX, Li RQ, He X, Lan BH, Zhang ZM, Liu GD, Xiao HL, Wu Y, Zhu B, Wang G, Yang ZZ. Li MX, et al. Among authors: zhu b, zhu yx. BMC Cancer. 2017 Apr 4;17(1):245. doi: 10.1186/s12885-017-3165-0. BMC Cancer. 2017. PMID: 28376735 Free PMC article.
Traditional Chinese Medicine Prolongs Progression-Free Survival and Enhances Therapeutic Effects in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)Treated Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations.
Tang M, Wang S, Zhao B, Wang W, Zhu Y, Hu L, Zhang X, Xiong S. Tang M, et al. Among authors: zhu y. Med Sci Monit. 2019 Nov 9;25:8430-8437. doi: 10.12659/MSM.917251. Med Sci Monit. 2019. PMID: 31704907 Free PMC article.
55,063 results
You have reached the last available page of results. Please see the User Guide for more information.